Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word?

Molecular Endocrinology

Volumn 18, Issue 2, 2004, Pages 269-278

  Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PHOSPHORYLASE PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN KINASE; SERINE; STEROID RECEPTOR;

CROSSING OVER; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENE FUNCTION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; MITOGENICITY; MOLECULAR DYNAMICS; MULTIGENE FAMILY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR SENSITIVITY; SHORT SURVEY; SIGNAL TRANSDUCTION; STIMULUS;

ANIMALS; CDC2-CDC28 KINASES; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; GTP PHOSPHOHYDROLASES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; SERINE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0842291441     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0331     Document Type: Short Survey

References (97)

1. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
2. Pratt WB 1998 The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc Soc Exp Biol Med 217:420-434
3. Pratt WB, Toft DO 2003 Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228:111-133
4. Moore MR, Zhou JL, Blankenship KA, Strobl JS, Edwards DP, Gentry RN 1997 A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol 62:243-252
5. Chalbos D, Chambon M, Ailhaud G, Rochefort H 1987 Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem 262: 9923-9926
6. Krusekopf S, Chauchereau A, Milgrom E, Henderson D, Cato AC 1991 Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J Steroid Biochem Mol Biol 40:239-245
7. Haraguchi S, Good RA, Engelman RW, Greene S, Day NK 1997 Prolactin, epidermal growth factor or transforming growth factor-α activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat. Mol Cell Endocrinol 129:145-155
8. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB 1997 Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11:1593-1607
9. Richer JK, Lange CA, Manning NG, Owen G, Powell R, Horwitz KB 1998 Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J Biol Chem 273:31317-31326
10. Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB 1998 Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273: 10696-10701
11. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW 1999 Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12
12. McKenna NJ, O'Malley BW 2002 Minireview: nuclear receptor coactivators - an update. Endocrinology 143: 2461-2465
13. Westin S, Rosenfeld MG, Glass CK 2000 Nuclear receptor coactivators. Adv Pharmacol 47:89-112
14. Horwitz KB, Alexander PS 1983 In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113:2195-2201
15. Weigel NL 1996 Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319:657-667
16. Takimoto GS, Hovland AR, Tasset DM, Melville MY, Tung L, Horwitz KB 1996 Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J Biol Chem 271:13308-13316
17. Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NL 1994 Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. J Biol Chem 269: 31034-31040
18. Zhang Y, Beck CA, Poletti A, Edwards DP, Weigel NL 1995 Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol 9:1029-1040
19. Zhang Y, Beck CA, Poletti A, Clement JPt, Prendergast P, Yip TT, Hutchens TW, Edwards DP, Weigel NL 1997 Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol Endocrinol 11:823-832
20. Knotts TA, Orkiszewski RS, Cook RG, Edwards DP, Weigel NL 2001 Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem 276:8475-8483
21. Lange CA, Shen T, Horwitz KB 2000 Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97: 1032-1037
22. Shen T, Horwitz KB, Lange CA 2001 Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21:6122-6131
23. Qiu M, Olsen A, Faivre E, Horwitz KB, Lange CA 2003 Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol Endocrinol 17:628-642
24. Font de Mora J, Brown M 2000 AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041-5047
25. Narayanan R, Adigun AA, Edwards DP, Weigel NL, Human progesterone receptor function is modulated by cyclin A/Cdk-2 and is impaired during the G2 phase of the cell cycle. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003 (Abstract OR5-2:65)
26. Labriola L, Salatino M, Proietti CJ, Pecci A, Coso OA, Kornblihtt AR, Charreau EH, Elizalde PV 2003 Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol Cell Biol 23:1095-1111
27. Bamberger AM, Bamberger CM, Gellersen B, Schulte HM 1996 Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc Natl Acad Sci USA 93:6169-6174
28. Migliaccio A, Di Domenico M, Green S, de Falco A, Kajtaniak EL, Blasi F, Chambon P, Auricchio F 1989 Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding. Mol Endocrinol 3:1061-1069
29. Ali S, Metzger D, Bornert JM, Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12:1150-1160
30. Qiu M, Lange CA 2003 MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. J Steroid Biochem Mol Biol 85:147-157
31. Haslam SZ, Counterman LJ, Nummy KA 1993 Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland. J Cell Physiol 155:72-78
32. Lange CA, Richer JK, Shen T, Horwitz KB 1998 Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J Biol Chem 273: 31308-31316
33. Nardulli AM, Katzenellenbogen BS 1988 Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 122:1532-1540
34. Salghetti SE, Kim SY, Tansey WP 1999 Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 18:717-726
35. Salghetti SE, Muratani M, Wijnen H, Futcher B, Tansey WP 2000 Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc Natl Acad Sci USA 97:3118-3123
36. Skowyra D, Craig KL, Tyers M, Elledge SJ, Harper JW 1997 F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91:209-219
37. Yaglom J, Linskens MH, Sadis S, Rubin DM, Futcher B, Finley D 1995 p34Cdc28-mediated control of Cln3 cyclin degradation. Mol Cell Biol 15:731-741
38. Imhof MO, McDonnell DP 1996 Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol Cell Biol 16:2594-2605
39. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW 1999 The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19: 1182-1189
40. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP 2001 Regulation of transcriptional activation domain function by ubiquitin. Science 293:1651-1653
41. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Linvingston DM 2003 Poly-ubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300:342-344
42. Mani SK, Allen JM, Clark JH, Blaustein JD, O'Malley BW 1994 Convergent pathways for steroid hormone-and neurotransmitter-induced rat sexual behavior. Science 265:1246-1249
43. Mani SK, Allen JM, Lydon JP, Mulac-Jericevic B, Blaustein JD, DeMayo FJ, Conneely O, O'Malley BW 1996 Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol 10:1728-1737
44. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW 1991 Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254: 1636-639
45. Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL 1998 Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol Cell Biol 18:1812-1825
46. Pierson-Mullany L, Lange CA, Regulation of progesterone receptor by phosphorylation of serine 400. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003 (Abstract OR5-3:65)
47. Edwards DP, Weigel NL, Nordeen SK, Beck CA 1993 Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat 27:41-56
48. Muratani M, Tansey WP 2003 How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4:192-201
49. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol Cell 5:939-948
50. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA 2001 FRAP reveals that mobility of oestrogen receptor-α is ligand-and proteasome-dependent. Nat Cell Biol 3:15-23
51. Wijayaratne AL, McDonnell DP 2001 The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276:35684-35692
52. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, Cheng S 2000 Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97:8985-8990
53. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA 1997 Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272:9287-9293
54. Wallace AD, Cidlowski JA 2001 Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276: 42714-42721
55. Schuetz AW 1967 Action of hormones on germinal vesicle breakdown in frog (Rana pipiens) oocytes. J Exp Zool 166:347-354
56. Schuetz AW 1977 Induction of oocytic maturation and differentiation: mode of progesterone action. Ann NY Acad Sci 286:408-420
57. Smith LD, Ecker RE 1969 Role of the oocyte nucleus in physiological maturation in Rana pipiens. Dev Biol 19: 281-309
58. Morrison T, Waggoner L, Whitworth-Langley L, Stith BJ 2000 Nongenomic action of progesterone: activation of Xenopus oocyte phospholipase C through a plasma membrane-associated tyrosine kinase. Endocrinology 141:2145-2152
59. Masui Y 2001 From oocyte maturation to the in vitro cell cycle: the history of discoveries of maturation-promoting factor (MPF) and cytostatic factor (CSF). Differentiation 69:1-17
60. Bayaa M, Booth RA, Sheng Y, Liu XJ 2000 The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism. Proc Natl Acad Sci USA 97:12607-12612
61. Tian J, Kim S, Heilig E, Ruderman JV 2000 Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc Natl Acad Sci USA 97: 14358-14563
62. Gotoh Y, Masuyama N, Dell K, Shirakabe K, Nishida E 1995 Initiation of Xenopus oocyte maturation by activation of the mitogen-activated protein kinase cascade. J Biol Chem 270:25898-25904
63. Kosako H, Gotoh Y, Nishida E 1994 Requirement for the MAP kinase kinase/MAP kinase cascade in Xenopus oocyte maturation. EMBO J 13:2131-2138
64. Bagowski CP, Xiong W, Ferrell Jr JE 2001 c-Jun N-terminal kinase activation in Xenopus laevis eggs and embryos. A possible non-genomic role for the JNK signaling pathway. J Biol Chem 276:1459-1465
65. Bagowski CP, Myers JW, Ferrell Jr JE 2001 The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J Biol Chem 276:37708-37714
66. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P 2003 Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100:2231-2236
67. Cato AC, Nestl A, Mink S 2002 Rapid actions of steroid receptors in cellular signaling pathways. SciSTKE 138: RE9
68. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A, Auricchio F 2002 Sex steroid hormones act as growth factors. J Steroid Biochem Mol Biol 83:31-35
69. Edwards DP, Wardell SE, Boonyaratanakornkit V 2002 Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. J Steroid Biochem Mol Biol 83:173-186
70. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/ p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
71. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F 1998 Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17:2008-2018
72. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280
73. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F 2000 Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417
74. Ballare C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, Auricchio F, Beato M 2003 Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol 23:1994-2008
75. Wong C, McNally C, Nickbarg E, Komm B, Cheskis B 2002 Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99: 14783-14788
76. Zhu Y, Bond J, Thomas P 2003 Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100:2237-2242
77. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836
78. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289:3243-3253
79. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, Migliaccio A, Auricchio F 1999 Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 18:2500-2510
80. Santen R, Jeng MH, Wang JP, Song R, Masamura S, McPherson R, Santner S, Yue W, Shim WS 2001 Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. J Steroid Biochem Mol Biol 79:115-125
81. Segars JH, Driggers PH 2002 Estrogen action and cytoplasmic signaling cascades. I. Membrane-associated signaling complexes. Trends Endocrinol Metab 13: 349-354
82. Driggers PH, Segars JH 2002 Estrogen action and cytoplasmic signaling pathways. II. The role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 13:422-427
83. Lannigan DA 2003 Estrogen receptor phosphorylation. Steroids 68:1-9
84. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG 1995 Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270:23589-23597
85. Reed SI 1997 Control of the G1/S transition. Cancer Surv 29:7-23
86. Sherr CJ 1996 Cancer cell cycles. Science 274: 1672-1677
87. Zhou Q, Hopp T, Fuqua SA, Steeg PS 2001 Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment. Cancer Lett 162:3-17
88. Cheng M, Sexl V, Sherr CJ, Roussel MF 1998 Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 95:1091-1096
89. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G 1994 Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817
90. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C 1995 Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9:2364-2372
91. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630
92. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
93. Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW 1996 Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 56:67-77
94. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME 2003 A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-334
95. Robinson GW, Johnson PF, Hennighausen L, Sterneck E 1998 The C/EBPβ transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev 12:1907-1916
96. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ, Rosen JM 1998 C/EBPβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 12:1917-1928
97. Clemm DL, Sherman L, Boonyaratanakornkit V, Schrader WT, Weigel NL, Edwards DP 2000 Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. Mol Endocrinol 14:52-65